New Economic Impact Report Finds a Healthy Pharmaceutical and Medical Technology Industry in New Jersey
New Brunswick, NJ, February 10, 2002 — While some New Jersey companies were laying off workers in 2001, New Jersey’s pharmaceutical and medical technology industry created more than 3,000 jobs during the year. The HealthCare Institute of New Jersey announced these findings and others in conjunction with the release of a study conducted by PricewaterhouseCoopers […]
New Jersey Pharmaceutical Companies Developed 53 Percent of FDA-Approved New Medicines in 2001
New Brunswick, NJ, January 28, 2002 — New Jersey-based pharmaceutical companies extended their decade-long dominance of the industry by developing 15 of the 24 new drugs approved by the U.S. Food and Drug Administration (FDA) in 2001. They were also responsible for the development of two of the eight newly approved biologics.